Mass-spectrometric analysis of agonist-induced retinoic acid receptor γ conformational change

Biochemical Journal

Volumn 362, Issue 1, 2002, Pages 173-181

  Peterson, Valerie J ^a   Barofsky, Elisabeth ^a   Deinzer, Max L ^a   Dawson, Marcia I ^a   Feng, Kai Chia ^a   Zhang, Xiao kun ^a   Madduru, Machender R ^a   Leid, Mark ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Conformation; MALDI; Nuclear receptors; Transcriptional co activators; Transcriptional co repressors

Indexed keywords

CELL CULTURE; CHEMICAL BONDS; COMPLEXATION; DESORPTION; DNA; IONIZATION; LASER APPLICATIONS; MASS SPECTROMETRY; PROTEINS;

NUCLEAR RECEPTORS;

BIOCHEMISTRY;

RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR GAMMA; RETINOIC ACID RECEPTOR GAMMA AGONIST; SR 11253; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; LIGAND BINDING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; HETEROCYCLIC COMPOUNDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, RETINOIC ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANS-ACTIVATORS;

EID: 0037084217     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3620173     Document Type: Article

References (50)

1. The coregulator exchange in transcriptional functions of nuclear receptors
2. Crystal structure of the ligand-binding domain of the human nuclear receptor RXRα
3. Conformational adaptation of agonists to the human nuclear receptor RARγ
4. Crystal structure of the RAR-γ ligand binding domain bound to all-trans retinoic acid
5. A canonical structure for the ligand-binding domain of nuclear receptors
6. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
7. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
8. Structure and specificity of nuclear receptor - Coactivator interactions
9. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
10. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
11. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
12. Molecular determinants of nuclear receptor - Corepressor interaction
13. Mechanism of corepressor binding and release from nuclear hormone receptors
14. Role of CBP/P300 in nuclear receptor signalling
15. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
16. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
17. The transcriptional coactivators p300 and CBP are histone acetyltransferases
18. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
19. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
20. GRIP1, a novel mouse protein that serves as a transcriptional co-activator in yeast for the hormone binding domains of steroid receptors
21. RAC3, a steroid/nuclear receptor-associated co-activator that is related to SRC-1 and TIF2
22. AIB1, a steroid receptor co-activator amplified in breast and ovarian cancer
23. Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
24. Coactivator and corepressor complexes in nuclear receptor function
25. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
26. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function
27. 6′-substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands
28. 9-cis-retinoic acid: Effects on normal and leukemic hematopoiesis in vitro
29. Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture
30. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells
31. p300 functions as a co-activator for the peroxisome proliferator-activated receptor α
32. Catecholaminergic CATH, a cells express predominantly δ-opioid receptors
33. Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ
34. Selective synthetïc ligands for human nuclear retinoic acid receptors
35. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ
36. Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors
37. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids
38. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells
39. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators
40. Recruitment of nuclear receptor corepressor and co-activator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions
41. Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: Divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes
42. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation
43. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor
44. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
45. Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping
46. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
47. Molecular basis of agonism and antagonism in the oestrogen receptor
48. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist
49. The structural basis of estrogen receptor/co-activator recognition and the antagonism of this interaction by tamoxifen
50. 289 in RARγ and its homologous amino acid residue of RARα and RARβ in the binding of retinoic acid